Abstract
Patients with severe COVID-19, especially those followed in the ICU, are at risk for developing bacterial and fungal superinfections. In this study, we aimed to describe the burden of hospital-acquired superinfections in a cohort of consecutive, severe COVID-19 patients hospitalized between February and May 2021 in the intensive care unit (ICU) department of San Salvatore Hospital in Pesaro, Italy. Among 89 patients considered, 68 (76.4%) acquired a secondary infection during their ICU stay. A total of 46 cases of ventilator-associated pneumonia (VAP), 31 bloodstream infections (BSIs) and 15 catheter-associated urinary tract infections (CAUTIs) were diagnosed. Overall mortality during ICU stay was 48%. A multivariate analysis showed that factors independently associated with mortality were male gender (OR: 4.875, CI: 1.227–19.366, p = 0.024), higher BMI (OR: 4.938, CI:1.356–17.980, p = 0.015) and the presence of VAP (OR: 6.518, CI: 2.178–19.510, p = 0.001). Gram-negative bacteria accounted for most of the isolates (68.8%), followed by Gram-positive bacteria (25.8%) and fungi (5.3%). Over half of the infections (58%) were caused by MDR opportunistic pathogens. Factors that were independently associated with an increased risk of infections caused by an MDR pathogen were higher BMI (OR: 4.378, CI: 1.467–13.064, p = 0.0008) and a higher Charlson Comorbidity Index (OR: 3.451, 95% CI: 1.113–10.700, p = 0.032). Secondary infections represent a common and life-threatening complication in critically ill patients with COVID-19. Efforts to minimize the likelihood of acquiring such infections, often caused by difficult-to-treat MDR organisms—especially in some subgroups of patients with specific risk factors—must be pursued.
Funder
Fondi Ricerca Scientifica di Ateneo
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference30 articles.
1. The Frequency of Influenza and Bacterial Coinfection: A Systematic Review and Meta-Analysis;Klein;Influenza Other Respir. Viruses,2016
2. Bacterial and Viral Infections Associated with Influenza;Joseph;Influenza Other Respir. Viruses,2013
3. Antibiotic Prescribing in Patients with COVID-19: Rapid Review and Meta-Analysis;Langford;Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis.,2021
4. Hospital-Acquired Infections in Critically Ill Patients With COVID-19;Grasselli;Chest,2021
5. Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19;Maes;Crit. Care Lond. Engl.,2021